戒烟药物疗法的优化使用。
Optimal use of smoking cessation pharmacotherapy.
作者信息
Mendelsohn Colin
机构信息
Double Bay, Sydney.
出版信息
Aust Prescr. 2022 Feb;45(1):10-14. doi: 10.18773/austprescr.2022.001. Epub 2022 Feb 1.
Abstract
The most effective intervention for stopping smoking is a combination of professional counselling and pharmacotherapy. Medicines are recommended for all smokers who are motivated to quit and are nicotine dependent. Combination nicotine replacement therapy with a patch and an oral product is more effective than the patch alone. An adequate dose of nicotine must be used for an adequate duration. Varenicline is the most effective oral drug. It is safe in people with stable mental illness. Vaping nicotine is a second-line treatment which can be considered for smokers who are unable to quit with other methods.
摘要
戒烟最有效的干预措施是专业咨询与药物治疗相结合。对于所有有戒烟意愿且尼古丁依赖的吸烟者，推荐使用药物。尼古丁贴片和口服产品联合使用的尼古丁替代疗法比单独使用贴片更有效。必须使用足够剂量的尼古丁并持续足够长的时间。伐尼克兰是最有效的口服药物。对患有稳定精神疾病的人来说它是安全的。吸电子烟是一种二线治疗方法，对于无法通过其他方法戒烟的吸烟者可以考虑使用。
相似文献
1
Optimal use of smoking cessation pharmacotherapy.戒烟药物疗法的优化使用。
Aust Prescr. 2022 Feb;45(1):10-14. doi: 10.18773/austprescr.2022.001. Epub 2022 Feb 1.
2
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.戒烟药物和电子烟：系统评价、网络荟萃分析和成本效益分析。
Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590.
3
Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.在适应性戒烟模式中，伐尼克兰/安非他酮联合治疗对高度依赖吸烟者有益。
Nicotine Tob Res. 2017 Aug 1;19(8):999-1002. doi: 10.1093/ntr/ntw283.
4
Treatment of Tobacco Smoking: A Review.烟草使用治疗：综述。
JAMA. 2022 Feb 8;327(6):566-577. doi: 10.1001/jama.2022.0395.
5
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.在有和没有精神疾病的吸烟者中，评估伐伦克林、安非他酮和尼古丁贴片的神经精神安全性和疗效（EAGLES）：一项双盲、随机、安慰剂对照临床试验。
Lancet. 2016 Jun 18;387(10037):2507-20. doi: 10.1016/S0140-6736(16)30272-0. Epub 2016 Apr 22.
6
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.
8
[Smoking cessation: Pharmacological strategies different from standard treatments].[戒烟：不同于标准治疗的药物策略]
Rev Pneumol Clin. 2018 Sep;74(4):205-214. doi: 10.1016/j.pneumo.2018.04.008.
9
Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.伐尼克兰联合尼古丁贴片对重度饮酒吸烟者戒烟效果的随机临床试验
JAMA Netw Open. 2022 Mar 1;5(3):e220951. doi: 10.1001/jamanetworkopen.2022.0951.
10
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.在比利时，与安非他酮、尼古丁替代疗法、简短咨询和无辅助戒烟相比，伐尼克兰的成本效益：一项BENESCO马尔可夫成本效益分析。
Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.
引用本文的文献
1
Does alcohol consumption elevate smoking relapse risk of people who used to smoke? Differences by duration of smoking abstinence.饮酒是否会增加曾经吸烟的人复吸的风险？与戒烟持续时间的差异。
J Subst Use Addict Treat. 2024 Apr;159:209260. doi: 10.1016/j.josat.2023.209260. Epub 2023 Dec 14.
2
Varenicline and Section 19A products for smoking cessation.伐尼克兰与第19A节戒烟产品。
Aust Prescr. 2022 Jun;45(3):74. doi: 10.18773/austprescr.2022.028. Epub 2022 Jun 1.
本文引用的文献
1
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
2
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Apr 29;4(4):CD010216. doi: 10.1002/14651858.CD010216.pub5.
3
E-cigarette use and respiratory disorders: an integrative review of converging evidence from epidemiological and laboratory studies.电子烟使用与呼吸系统疾病：来自流行病学和实验室研究的综合证据综述
Eur Respir J. 2021 Jan 21;57(1). doi: 10.1183/13993003.01815-2019. Print 2021 Jan.
4
COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up.转而使用电子烟的慢性阻塞性肺疾病吸烟者：5年随访的健康结果
Ther Adv Chronic Dis. 2020 Oct 10;11:2040622320961617. doi: 10.1177/2040622320961617. eCollection 2020.
5
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法的不同剂量、疗程和给药方式。
Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308. doi: 10.1002/14651858.CD013308.
6
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy.一项电子烟与尼古丁替代疗法的随机试验。
N Engl J Med. 2019 Feb 14;380(7):629-637. doi: 10.1056/NEJMoa1808779. Epub 2019 Jan 30.
7
The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention.电子烟在支持吸烟复发预防方面减少烟草危害的独特贡献。
Harm Reduct J. 2018 Jun 20;15(1):31. doi: 10.1186/s12954-018-0237-7.
8
Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.伐伦克林、安非他酮和尼古丁贴片在吸烟者中的心血管安全性：一项随机临床试验。
JAMA Intern Med. 2018 May 1;178(5):622-631. doi: 10.1001/jamainternmed.2018.0397.
9
Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes.电子烟随机戒烟试验中的肺功能和呼吸道症状
Clin Sci (Lond). 2016 Nov 1;130(21):1929-37. doi: 10.1042/CS20160268. Epub 2016 Aug 19.
10
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
Zotero 插件